Clinical Trials

Find a Trial

Trial Summary

Protocol No.PHO-PRADHAN-COG-ADVL1521
StatusOPEN TO ACCRUAL
Principal InvestigatorPradhan, Kamnesh
ScopeNational
PhasePhase II
Age GroupChildren
TitleA Phase 2 Study of the MEK Inhibitor Trametinib in Children with Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Applicable Disease SitesLeukemia, other
Participating InstitutionsIndiana University (IU)
  • Riley Hospital for Children
Treatment TypeTreatment
ContactMelissa Lee, Phone: 317-944-4281
Pager: 312-1228
Email: mellee@iu.edu